https://www.selleckchem.com/pr....oducts/stat-in-1.htm
Thirty-day mortality (7%, 4% and 2%), stroke (7%, 3% and 3%), need for apacemaker (19%, 22% and 8%) and delirium (17%, 12% and 8%) improved significantly, while major bleeding/vascular complications did not change (both approximately 9%, 6% and 6%). One-year survival was 80%, 88% and 92%, respectively. Over our 15years' experience, patient age remained unchanged but the patient risk profile became more favourable. Simplification of the TAVI procedure occurred in parallel with major improvement in outcomes and survival. Bleeding/vascul
Like
Comment
Share
